Navigation Links
CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China
Date:7/21/2014

ROCKVILLE, Md., July 21, 2014 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that China's Food and Drug Administration (CFDA) has approved the Company's application to conduct a Phase II clinical trial in triple-negative breast cancer (TNBC) patients in China for its proprietary drug candidate, ENMD-2076. 

Ken K. Ren, Ph.D., CASI's Chief Executive Officer, commented, "CFDA's approval of our application represents a significant and exciting milestone for CASI in the execution of our China and global integrated development strategy.  Our Phase II TNBC trial of ENMD-2076 in the U.S. is progressing as planned, and we can now further expand the trial into China with the recruitment of more patients. Data from the China trial can be combined with data being collected in the U.S., and may lead to reaching a clinical inflection point faster. In addition, the China trial will enable us to evaluate the safety and efficacy of ENMD-2076 in the Chinese patient population, providing an opportunity to address unmet medical needs in the country.  Furthermore, data from this trial may be used to support our import drug registration in China in the future."

Dr. Ren continued, "Our development team in Beijing is working closely with our principal investigator and key opinion leaders from leading oncology centers in China in preparation for the trial. We intend to conduct additional trials there as an important component of our China<
'/>"/>

SOURCE CASI Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015 Zynerba Pharmaceuticals, Inc. today announced ... with the U.S. Securities and Exchange Commission (SEC) relating to ... number of shares to be offered and the price range ... Jefferies LLC and Piper Jaffray & Co. will ... Genuity Inc. and Oppenheimer & Co. Inc. will act as ...
(Date:6/30/2015)... June 30, 2015 A new analysis ... exposure to high-priced Hepatitis C medications could range ... percent of Californians infected with Hepatitis C receive treatment through ... of new Hepatitis C treatments on public programs, comes at ... price tags for drugs like Gilead Sciences, Harvoni and Sovaldi. ...
(Date:6/30/2015)...  Today, the National Mobility Equipment Dealers Association (NMEDA) ... Awareness Month Local Heroes Contest on National TV. The ... received 1.3 million votes. The sponsors for the wheelchair ... , and Valley Honda Dealers , with the ... Mobility International (VMI) and ElDorado Mobility .  ...
Breaking Medicine Technology:Zynerba Files Registration Statement for Proposed Initial Public Offering of Common Stock 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 3New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 4NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3
... with West Nile Virus and populations ... PURCHASE, N.Y., Sept. 9 A recently ... by the Division of,Vector-Borne Infectious Diseases with the ... that AHCC(R) (Active Hexose Correlated,Compound) enhances host resistance ...
... Epiphany Biosciences, Inc. today,announced that a Phase 2b ... of the company,s lead compound, valomaciclovir,(EPB-348) in patients ... originally designed following an interim analysis., Fred ... with the,progress of this clinical trial and look ...
Cached Medicine Technology:Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus 2Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus 3Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN) 2
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... CCAR is ... three Recovery Community Centers in Hartford, Willimantic and Bridgeport. This month, staff member ... first Recovery Coach Manager. He is excited to take on this role of ...
(Date:6/30/2015)... NY (PRWEB) , ... June 30, 2015 , ... ... newest oncology centers are partnering to improve access to cancer prevention, screening and ... Cancer Center (LCC) have announced an affiliation that will see Roswell Park faculty ...
(Date:6/30/2015)... ... June 30, 2015 , ... Independence Day weekend is more than ... and official kick off of July as National Hot Dog Month. Americans are expected ... any other time of the year and enough to stretch from Washington D.C. to ...
(Date:6/30/2015)... ... June 30, 2015 , ... After more than five years of research ... GlobalSun (TM) — sunscreen specifically formulated for the unique skin of all people of ... the market just in time to help protect the skin of all people of ...
(Date:6/30/2015)... ... June 30, 2015 , ... LifeAID Beverage Company has ... leading organizations dedicated to raising worldwide awareness of the burgeoning “adaptive” movement, I ... now the official charity of FitAID. I AM ADAPTIVE is a non-profit whose ...
Breaking Medicine News(10 mins):Health News:The Connecticut Community for Addiction Recovery takes Recovery Coaching to a new level 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 4Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 5Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2Health News:GlobalSun – The First Sunscreen Developed for All People of Color – Hits The Market 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 3
... drinks and foods permanently destroys,enamel, CHICAGO, Sept. 4 ... harmless snacks and beverages, but improper,consumption and overuse may ... as tooth erosion, and an online member poll conducted ... feel tooth,erosion is more common today compared to five ...
... because of side effect concerns, study finds , TUESDAY, Sept. ... asthma drugs may prevent asthmatic children from getting the relief ... released in the September issue of Pediatrics , one ... about the side effects of asthma medications than their child,s ...
... Marlabs, Inc. has been named by,the Brown-Wilson ... of Top 10 BPO,healthcare revenue cycle management companies. ... to outsourcing users and,decision makers globally, garnering over ... Marlabs,s CEO Siby Vadakekkara attributes the recognition to ...
... BlueShield of South,Carolina plans to electronically integrate personal ... available in real time to BlueCross,members and their ... provider and integrator of care and,disease management services, ... Management platform available to other insurance companies. ...
... insurance calculator available in conjunction with Life ... Insurance Awareness Month, ... United States find buying life,insurance complex and confusing -- half don,t ... wrong decision (1). To help consumers learn,more about life insurance, CIGNA ...
... a novel solution; a disposable sheet that will protect travelers from the ... current ... size,of only an apple seed, these flat, oval insects that feed on ... comeback. Nearly,eradicated since World War II, they,re back in droves, infesting homes,hotels, ...
Cached Medicine News:Health News:Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion 2Health News:Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion 3Health News:Parents' Worries Hamper Kids' Asthma Treatment 2Health News:Marlabs in the Top 10 BPO Healthcare Revenue Cycle Management Companies 2Health News:S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time 2Health News:S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time 3Health News:CIGNA Group Insurance Shows Consumers 'There's More to Life' Through a New Consumer Education Toolkit 2Health News:CIGNA Group Insurance Shows Consumers 'There's More to Life' Through a New Consumer Education Toolkit 3Health News:No Sheet: New Disposable Cover Keeps Bed Bugs at Bay 2Health News:No Sheet: New Disposable Cover Keeps Bed Bugs at Bay 3
The Protract stem offers a press-fit option which will allow choice of standard or lateralized neck offsets while keeping a consistent leg length....
M2 cemented hip stem....
Cemented foundation 450 series....
A cementless femoral stem that promotes bone in-growth and reduces thigh pain....
Medicine Products: